It all started when…
in 2009 Erik Hack started the Inflammation Research Lab of the Departments of Rheumatology and Dermatology in the University Medical Center Utrecht (UMCU) and decided to focus its research on improving the therapeutic potential of interleukins
the story behind our innnovation
At the University Medical Center of Utrecht (UMCU, The Netherlands) a new approach to treat chronic pain was identified in the research of the interaction between the immune system and pain pathways.
March 25, 2019 Synerkine Pharma Raises EUR3.3 Million in Series A Financing